Human single B cell antibody technology
Human single B cell antibody technology is an efficient and cutting-edge approach to discovery human monoclonal antibody from vaccine recipients or convalescent patients. The standard process includes the screening of antigen-specific memory B cells, the amplification of variable region, the construction of expression vector, the production and characterization of human antibodies.
Feature
- Obtain relevant human antibody sequences in 1 month.
- Acquire naturally derived human antibodies from relevant subjects.
- Gain human antibodies against different epitopes in single run.
Application
Discover antigen-specific and functional therapeutic antibodies for infectious or other disease area.
Status
The standardized procedure for this technology platform is well established. The options of customized fee-for-service or co-development are open for discussion.